IMR Press / FBL / Volume 8 / Issue 6 / DOI: 10.2741/985

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.


Molecular epidemiology of Streptococcus agalactiae (group B Streptococcus)

Show Less
1 Department of Epidemiology, University of Michigan School of Public Health, University of Michigan, 109 S. Observatory, Ann Arbor, MI 48843, USA

Academic Editor: Carl Marrs

Front. Biosci. (Landmark Ed) 2003, 8(6), 1–18;
Published: 1 January 2003
(This article belongs to the Special Issue Molecular epidemiology of Infectious diseases)

Group B Streptococcus (GBS) is a common cause of sepsis and meningitis in newborns, and causes disease in pregnant women and non-pregnant adults. The incidence of disease among non-pregnant adults, particularly those with underlying conditions, is increasing. In addition, many individuals are asymptomatically colonized with GBS. When compared to group A Streptococcus and Streptococcus pneumoniae, however, little is known about the pathogenesis, natural history and transmission dynamics of GBS. Various molecular tools have been utilized to study this organism, including both phenotypic techniques, such as serotyping and multilocus enzyme electrophoresis, and genotypic techniques such as plasmid analysis and pulsed-field gel electrophoresis. This review outlines the contributions of these methods to our current understanding of GBS infections.

Streptococcus agalactiae
Group B Streptococcus
molecular epidemiology
Back to top